BAT Launches Virtual R&D Visitor Experience, Showcasing World-Class Science Behind Next-Generation Reduced-Risk* Nicotine Products


BAT has created a Virtual R&D Visitor Experience, an online tour of its global research and development center in Southampton, UK, which allows people to explore its cutting-edge science and innovation.

The experience builds on BAT’s open and transparent approach to the science that underpins its reduced-risk* product portfolio and beyond nicotine business. The company regularly welcomes in-person visitors to its global R&D center, with more than 3,500 people visiting the facilities first-hand since 2011. However, with travel significantly reduced, the virtual experience allows people around the world to access and understand the scientific knowledge of BAT. research, tobacco harm reduction (THR) activities and to obtain expert views and ideas.

Dr David O’Reilly, Director of Scientific Research at BAT, said: “At BAT, R&D is fundamental to what we do. Our focus on science and research has allowed us to make significant progress in the development and evolution of our next-in-class products, which are rigorously tested and scientifically proven as reduced-risk* alternatives to cigarettes. Our R&D is based on consumer preferences, as well as the application of scientific evolution and innovation to our products. This allows us to offer a range of enjoyable and lower-risk* alternatives to cigarettes while ensuring we maintain very high standards of safety and quality.

“Our new R&D virtual visitor experience demonstrates the breadth of science we undertake and the robust scientific framework we use to evaluate and support the role our products play in reducing the harms of tobacco.”

With 360-degree lab tours, animations, videos, scientist profiles, podcasts, and more, R&D

Virtual Visitor Experience is the one stop shop for those looking to learn more about the science of BAT. Visit sheds light on BAT’s goal of building a better futureMT and mission to reduce the health impact of its activity. BAT invests nearly £350m a year to find innovative ways to reduce its effects on public health and aims to have 50m consumers of its non-combustible products by 2030.

BAT conducts research in a wide range of scientific fields, including molecular biology, toxicology and chemistry, fueling the relentless innovation and learning that sets the company apart as an industry leader.

Visitors to the R&D virtual experience will be able to explore:

  • Sensory sciences: This unique department helps BAT better understand the consumer product experience and decode that experience into actionable insights that support product and brand development
  • Biotechnology laboratory: Here, BAT scientists leverage their expertise in whole genome sequencing, metabolomics, and computational biology to deliver enhanced customer experiences. Teams are also growing plants and identifying sustainable sources of compounds
  • Biology laboratory: This is where scientists test products from the new class of BAT for their potential impact on human cells compared to cigarette smoke.
  • Battery lab: This facility has revolutionized the way BAT’s rechargeable devices are designed, developed and tested. Batteries are tested to ensure they meet high quality standards.

Comments are closed.